260 results on '"Sager, Hendrik B."'
Search Results
2. Neuroimmune crosstalk: How mental stress fuels vascular inflammation
3. Incidence and pattern of urgent revascularization in acute coronary syndromes treated with ticagrelor or prasugrel
4. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors
5. Modified balloons to prepare severely calcified coronary lesions before stent implantation: a systematic review and meta-analysis of randomized trials
6. A Ten-Year Follow-Up Study of the Association Between Uric Acid and Adverse Cardiovascular Events in Patients With Coronary Artery Disease
7. In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using 68Ga-NOTA-Anti-MMR Nb: Targeting Mannose Receptor (MR, CD206) on M2 Macrophages
8. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
9. Tiempos para la revascularización multivaso en pacientes estables con IAMCEST: revisión sistemática y metanálisis en red
10. Timing of multivessel revascularization in stable patients with STEMI: a systematic review and network meta-analysis
11. Clinician Scientists in der kardiovaskulären Medizin: Positionspapier der Deutschen Gesellschaft für Kardiologie
12. Loss of soluble guanylyl cyclase in platelets contributes to atherosclerotic plaque formation and vascular inflammation
13. Índice de masa corporal y eficacia y seguridad del ticagrelor frente al prasugrel en pacientes con síndrome coronario agudo
14. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors.
15. Aspirin loading and coronary no‐reflow after percutaneous coronary intervention in patients with acute myocardial infarction
16. Efficacy and safety of ticagrelor versus prasugrel in smokers and nonsmokers with acute coronary syndromes
17. Ticagrelor or Prasugrel in Patients With Acute Coronary Syndrome and High Bleeding Risk
18. Macrophages Facilitate Electrical Conduction in the Heart
19. Prediction of risk for bleeding, myocardial infarction and mortality after percutaneous coronary intervention in patients with acute coronary syndromes
20. Coronary no-reflow and adverse events in patients with acute myocardial infarction after percutaneous coronary intervention with current drug-eluting stents and third-generation P2Y12 inhibitors
21. Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair
22. Identification of a Functional PDE5A Variant at the Chromosome 4q27 Coronary Artery Disease Locus in an Extended Myocardial Infarction Family
23. ADAMTS-7 Modulates Atherosclerotic Plaque Formation by Degradation of TIMP-1
24. Leukocytes carryingClonal Hematopoiesis of Indeterminate Potential(CHIP) Mutations invade Human Atherosclerotic Plaques
25. Functional investigation of the coronary artery disease gene SVEP1
26. Ticagrelor or Prasugrel in Patients With ST-Segment–Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
27. Clinician scientists in cardiovascular medicine Position paper of the German Cardiac Society
28. Leukocytes carrying Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutations invade Human Atherosclerotic Plaques.
29. Targeting mannose receptor expression on macrophages in atherosclerotic plaques of apolipoprotein E-knockout mice using 68Ga-NOTA-anti-MMR nanobody: non-invasive imaging of atherosclerotic plaques
30. The novel coronary artery disease risk factor ADAMTS-7 modulates atherosclerotic plaque formation by degradation of TIMP-1
31. Role of the extracellular matrix in cell–cell communication: a new therapeutic target?
32. The Impact of Exercise on Immunity, Metabolism, and Atherosclerosis
33. Time-of-day at symptom onset was not associated with infarct size and long-term prognosis in patients with ST-segment elevation myocardial infarction
34. Prior Myocardial Infarction and Treatment Effect of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndromes ‐ A Post‐hoc Analysis of the ISAR‐REACT 5 Trial
35. Quo Vadis? Immunodynamics of Myeloid Cells after Myocardial Infarction
36. Clinician Scientists in der kardiovaskulären Medizin
37. Association of In‐Hospital Hemoglobin Drop With Decreased Myocardial Salvage and Increased Long‐Term Mortality in Patients With Acute ST‐Segment–Elevation Myocardial Infarction
38. Body mass index and efficacy and safety of ticagrelor versus prasugrel in patients with acute coronary syndromes
39. Access Route and Clinical Outcomes After Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome Undergoing Invasive Treatment Strategy
40. Ticagrelor or prasugrel in patients with acute coronary syndrome with off-hour versus on-hour presentation: a subgroup analysis of the ISAR-REACT 5 trial
41. Colchicine Impacts Leukocyte Trafficking in Atherosclerosis and Reduces Vascular Inflammation
42. Inflammation and cardiovascular disease: new epidemiologic data and their potential implications for anti-cytokine therapy.
43. In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using 68 Ga-NOTA-Anti-MMR Nb: Targeting Mannose Receptor (MR, CD206) on M2 Macrophages.
44. In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using 68Ga-NOTA-Anti-MMR Nb: Targeting Mannose Receptor (MR, CD206) on M2 Macrophages
45. In vivo Visualization of M2 Macrophages in the Myocardium After Myocardial Infarction (MI) Using ⁶⁸Ga-NOTA-Anti-MMR Nb : Targeting Mannose Receptor (MR, CD206) on M2 Macrophages
46. Pre-admission antiplatelet therapy and treatment effect of ticagrelor vs. prasugrel in patients with acute coronary syndromes—a subgroup analysis of the ISAR-REACT 5 trial
47. Mental health-related risk factors and interventions in patients with heart failure: a position paper endorsed by the European Association of Preventive Cardiology (EAPC)
48. Where the Action Is—Leukocyte Recruitment in Atherosclerosis
49. Impact of Acute and Chronic Psychosocial Stress on Vascular Inflammation
50. Assessment of Impact of Patient Recruitment Volume on Risk Profile, Outcomes, and Treatment Effect in a Randomized Trial of Ticagrelor Versus Prasugrel in Acute Coronary Syndromes
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.